Epidermal growth factor receptor and AKT 1 gene copy numbers by multi‐gene fluorescence in situ hybridization impact on prognosis in breast cancer-Reference-Cited by-同舟云学术

Epidermal growth factor receptor and AKT 1 gene copy numbers by multi‐gene fluorescence in situ hybridization impact on prognosis in breast cancer

Published:2015-03-16 Issue:5 Volume:106 Page:642-649
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Li Jiao¹,Su Wei¹,Zhang Sheng¹,Hu Yunhui¹,Liu Jingjing¹,Zhang Xiaobei¹,Bai Jingchao¹,Yuan Weiping²,Hu Linping²,Cheng Tao²,Zetterberg Anders³,Lei Zhenmin⁴,Zhang Jin¹

Affiliation:

1. Key Laboratory of Breast Cancer Prevention and Therapy Tianjin Medical University Ministry of Education Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer China Tianjin Breast Cancer Prevention, Treatment and Research Center Key Laboratory of Cancer Prevention and Therapy TianjinChina

2. Beijing Union Medical College Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin China

3. Clinical Pathology Department of Karolinska Hospital Karolinska Institute Solna Sweden

4. Department of OB/GYN University of Louisville School of Medicine Louisville Kentucky USA

Funder

Chinese National Natural Sciences Foundation

National science and technology support program

Tianjin municipal Major Scientific and Technological Special Project for Significant Anticancer Development

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12637

Reference45 articles.

1. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

2. Comprehensive molecular portraits of human breast tumours

3. The landscape of cancer genes and mutational processes in breast cancer

4. Whole-genome analysis informs breast cancer response to aromatase inhibition

5. ERBB receptors and cancer: the complexity of targeted inhibitors

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Mechanism of Myrrh in the Treatment of Breast Cancer Based on Network Pharmacology and Cell Experiments;Chemical Biology & Drug Design;2024-08

2. LCN2: Versatile players in breast cancer;Biomedicine & Pharmacotherapy;2024-02

3. KLK10/LIPH/PARD6B/SLC52A3 are promising molecular biomarkers for the prognosis of pancreatic cancer through a ceRNA network;Heliyon;2024-01

4. Downregulation of the long noncoding RNA DSCR9 (Down syndrome critical region 9) delays breast cancer progression by modulating microRNA-504-5p-dependent G protein-coupled receptor 65;Human Cell;2023-05-29

5. Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single-cell level by QM-FISH;Blood Advances;2022-01-17